Rasburicase for Treatment of Hyperuricemia in Children & Adolescence

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05434858` - Imagery as Biomarker of Gout	N/A
Completed	`NCT04060173` - A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ABP-671	Phase 1
Recruiting	`NCT05504083` - Evaluate the Efficacy and Safety of D-0120 in Primary Hyperuricemia Patients	Phase 2
Completed	`NCT04966325` - Thorough QT (TQT) Study to Evaluate the Effect of LC350189 on Cardiac Repolarization in Healthy Male and Female Subjects	Early Phase 1
Completed	`NCT01407874` - A Randomized, Double-Blind, Dose-Response Study of the Safety and Uric Acid Effects of Oral Ulodesine Added to Allopurinol in Subjects With Gout and Concomitant Moderate Renal Insufficiency	Phase 2
Completed	`NCT00995618` - Study of Tranilast Alone or in Combination With Febuxostat in Patients With Hyperuricemia	Phase 2
Completed	`NCT00288158` - Primary Prevention of Hypertension in Obese Adolescents	Phase 2
Terminated	`NCT04987294` - Phase IIa Study of ALLN-346 (Engineered Urate Oxidase) in Subjects With Hyperuricemia, Gout and Chronic Kidney Disease	Phase 2
Completed	`NCT04236219` - ALLN-346 Single Ascending Dose (SAD) Study in Healthy Volunteers	Phase 1
Completed	`NCT06189404` - Effect of Tigulixostat on the Pharmacokinetics of Theophylline	Phase 1
Recruiting	`NCT05586958` - Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients	Phase 3
Recruiting	`NCT06084585` - The Efficacy of Amway Uric Acid Lowering Product on Hyperuricemia	N/A
Recruiting	`NCT06056570` - Open Label PK, PD and DDI of Dotinurad and Allopurinol in Gout Patients With Hyperuricemia	Phase 1/Phase 2
Not yet recruiting	`NCT04586803` - Study on the Bioavailability of Three Different Prescription Processes of SHR4640 Tablets in Healthy Volunteers	Phase 1
Completed	`NCT02959918` - Multi-Dose Safety/Pharmacodynamic Study of SEL-212/SEL-037 in Subjects With Symptomatic Gout & Elevated Blood Uric Acid	Phase 2
Not yet recruiting	`NCT02944214` - Compare the Renal Protective Effects of Febuxostat and Benzbromarone in CKD Chinese Patients	N/A
Completed	`NCT02557126` - Study of URC102 to Assess the Safety and Efficacy in Gout Patients	Phase 2
Active, not recruiting	`NCT01021241` - Safety and Efficacy Study of Intravenous Uricase-PEG 20	Phase 1
Completed	`NCT00756964` - Lowering Serum Uric Acid to Prevent Acute Kidney Injury	Phase 2
Terminated	`NCT00607152` - Rasburicase (Fasturtec) Registration Trial	Phase 3

NCT number	NCT00563771
Study type	Interventional
Source	Sanofi
Contact
Status	Completed
Phase	Phase 4
Start date	March 2003
Completion date	January 2004

Rasburicase for Treatment of Hyperuricemia in Children and Adolescence Patients With Tumor Lysis Syndrome

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms